Nkarta, Inc. (NKTX)
2.71
-0.05
(-1.81%)
USD |
NASDAQ |
Aug 31, 16:00
2.69
-0.02
(-0.74%)
After-Hours: 20:00
Nkarta Cash from Operations (TTM) : -92.76M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -92.76M |
| March 31, 2026 | -87.29M |
| December 31, 2025 | -88.70M |
| September 30, 2025 | -91.80M |
| June 30, 2025 | -97.66M |
| March 31, 2025 | -100.80M |
| December 31, 2024 | -99.70M |
| September 30, 2024 | -98.30M |
| June 30, 2024 | -94.03M |
| March 31, 2024 | -93.91M |
| December 31, 2023 | -86.16M |
| September 30, 2023 | -70.14M |
| June 30, 2023 | -64.66M |
| March 31, 2023 | -59.50M |
| Date | Value |
|---|---|
| December 31, 2022 | -57.00M |
| September 30, 2022 | -67.24M |
| June 30, 2022 | -70.70M |
| March 31, 2022 | -71.54M |
| December 31, 2021 | -67.93M |
| September 30, 2021 | -63.21M |
| June 30, 2021 | -57.08M |
| March 31, 2021 | -49.87M |
| December 31, 2020 | -43.51M |
| September 30, 2020 | -37.29M |
| June 30, 2020 | -29.81M |
| March 31, 2020 | -22.84M |
| December 31, 2019 | -18.37M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Theriva Biologics, Inc. | -12.74M |
| Unicycive Therapeutics, Inc. | -27.84M |
| OnKure Therapeutics, Inc. | -47.84M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |